1. Home
  2. SLDP vs LYEL Comparison

SLDP vs LYEL Comparison

Compare SLDP & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solid Power Inc.

SLDP

Solid Power Inc.

HOLD

Current Price

$2.91

Market Cap

714.7M

Sector

Energy

ML Signal

HOLD

Logo Lyell Immunopharma Inc.

LYEL

Lyell Immunopharma Inc.

HOLD

Current Price

$20.80

Market Cap

490.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLDP
LYEL
Founded
2011
2018
Country
United States
United States
Employees
230
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
714.7M
490.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SLDP
LYEL
Price
$2.91
$20.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$7.00
$27.25
AVG Volume (30 Days)
3.2M
82.2K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$36,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$48.90
$17,438.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$0.39
52 Week High
$8.86
$45.00

Technical Indicators

Market Signals
Indicator
SLDP
LYEL
Relative Strength Index (RSI) 36.41 48.33
Support Level N/A $16.20
Resistance Level $3.22 $27.30
Average True Range (ATR) 0.16 1.83
MACD 0.02 0.13
Stochastic Oscillator 22.86 73.02

Price Performance

Historical Comparison
SLDP
LYEL

About SLDP Solid Power Inc.

Solid Power Inc develops solid-state battery technology and manufacturing processes. Its sulfide-based solid electrolyte material replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells and enables improvement in energy density, battery life and safety performance. The company produces electrolytes on two pilot manufacturing lines using a batch manufacturing process for customer sampling and internal cell development, and manufactures solid-state cells on pre-pilot and pilot cell manufacturing lines. Its cell manufacturing processes are developed around industry-standard lithium-ion battery manufacturing processes and equipment, and it manufactures all cell designs, including cathodes and anodes, using materials sourced from external suppliers.

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

Share on Social Networks: